Table of Contents
PharmSights
| Implications and Development of AHR-based Therapeutic Agents |
Abstract PDF |
| Eun-Young Choi, Hyosung Lee, R.W. Cameron Dingle, Kyung Bo Kim, Hollie I. Swanson |
53-60 |
| A Main Role for Metabotropic Glutamate Receptor 1 in the Neuroprotective Effect of Estrogen |
Abstract PDF |
| Simona Federica Spampinato, Sara Merlo, Ferdinando Nicoletti, Maria Angela Sortino |
61-67 |
Reviews
| Anticancer Activity and Molecular Mechanisms of Action of Makaluvamines and Analogues |
Abstract PDF |
| Subhasree Nag, Dwayaja H. Nadkarni, Jiang-Jiang Qin, Sukesh Voruganti, Thao Nguyen, Su Xu, Wei Wang, Hui Wang, Sadanandan E. Velu, Ruiwen Zhang |
69-81 |
FDA Corner
| FDA Approves Varizig for Reducing Chickenpox Symptoms |
Abstract PDF |
| |
83 |
| FDA Approves Xeljanz for Rheumatoid Arthritis |
Abstract PDF |
| |
83-84 |
| FDA Approves Synribo for Chronic Myelogenous Leukemia |
Abstract PDF |
| |
84-85 |
| FDA Approves New Treatment for Advanced Colorectal Cancer |
Abstract PDF |
| |
85 |
LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041
Copyright © 2008 LumiText Publishing. All rights reserved.
